OR WAIT null SECS
Grant Playter is Associate Editor for Pharmaceutical Technology, BioPharm International, and Pharmaceutical Technology Europe.
June 21, 2023
FDA’s new voluntary pilot program is designed to help clinicians select appropriate cancer treatments for patients.